Critical Outcome Technologies Inc. is a Canadian biotechnology firm based in London, Ontario, specializing in the development of innovative therapeutic solutions. The company focuses on advancing drug discovery and development processes, particularly in the fields of oncology and other serious diseases. By leveraging proprietary technologies, Critical Outcome aims to enhance the efficiency and effectiveness of treatment options, ultimately improving patient outcomes and addressing unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#13 in London

#983 in Canada

#39,921 in the World

London, Canada

Critical Outcome Technologies Inc.

Forward Citations = 45

16 inventors:

Wayne Danter (14 out of 15 patents)

Martyn A Brown (6 out of 8 patents)

Clinton Threlfall (4 out of 4 patents)

4. Franck LePifre (4 out of 6 patents)

5. Sylvain Guizzetti (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Critical Outcome Technologies Inc.. Retrieved from https://idiyas.com/company/critical-outcome-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]